The utilization of plasma albumin as a pharmaceutical transporter is expected to exhibit a propensity for selective distribution towards tumor tissues as opposed to normal tissues, owing to the augmented permeability and retention of tumors caused by vascular leakage and compromised lymphatic drainage. The gene discussed is ALB; the disease is neoplasm.